Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026 and Jun 2026.
- Largest single sale: $1.1M (11,741 shares) of Kymera Therapeutics, Inc. on Jun 17, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Director | Aug 20, 2020 | Jul 2, 2026 |
| Sionna Therapeutics, Inc. (SION) | Director | Feb 6, 2025 | Jun 18, 2026 |
| Dianthus Therapeutics, Inc. (DNTH) | Former Director | Jun 20, 2018 | Jun 30, 2022 |
| Cogent Biosciences, Inc. (COGT) | Former Director | Mar 28, 2018 | Jul 6, 2020 |
Also a director at
Sionna Therapeutics, Inc. (SION), Dianthus Therapeutics, Inc. (DNTH) (no filing in the last 18 months), Cogent Biosciences, Inc. (COGT) (no filing in the last 18 months)
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 17, 2026, Kymera Therapeutics, Inc.: sold 11,741 shares for $1.1M, under a disclosed plan; 11,741 shares acquired by exercising options. 1 filing: 1
- Apr 22, 2026, Kymera Therapeutics, Inc.: sold 5,900 shares for $531K, under a disclosed plan; 5,900 shares acquired by exercising options. 1 filing: 1
- Apr 15, 2026, Kymera Therapeutics, Inc.: sold 2,200 shares for $198K, under a disclosed plan; 2,200 shares acquired by exercising options. 1 filing: 1
- Apr 14, 2026, Kymera Therapeutics, Inc.: sold 4,159 shares for $374K, under a disclosed plan; 4,159 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.